Annovis Bio, Inc.
ANVS$36M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaMALVERN
Drugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
ANVS News
Catalyst Timeline
0 upcoming, 2 past
No catalysts found.
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
buntanetap/posiphen | Phase 3 | Parkinson's Disease, Idiopathic | - | - |
Posiphen | Phase 2 | Alzheimer's Disease | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply